NVA237 einmal täglich bietet schnelle, klinisch bedeutsame und 24h anhaltende Bronchodilatation bei COPD-Patienten: die GLOW1 Studie

  • A D'Urzo, GT Ferguson, M Kato, S Atis, C Martin, VKT Alagappan, D Banerji, Y Lu, T Overend, S Korn
  • Pneumologie, February 2012, Thieme Publishing Group
  • DOI: 10.1055/s-0032-1302821

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Vijay Kumar Thyagarajan Alagappan